Page last updated: 2024-08-21

dronabinol and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

dronabinol has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ginovart, N; Ibanez, V; Millet, P; Moulin-Sallanon, M; Steimer, T; Tournier, BB1
Ceccarini, J; Henquet, C; Kuepper, R; Lataster, J; Marcelis, M; van Gerven, JM; van Kroonenburgh, M; Van Laere, K; van Os, J1

Other Studies

2 other study(ies) available for dronabinol and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

ArticleYear
Chronic Ī”ā¹-tetrahydrocannabinol exposure induces a sensitization of dopamine Dā‚‚/ā‚ƒ receptors in the mesoaccumbens and nigrostriatal systems.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:11

    Topics: Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Benzamides; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fluorodeoxyglucose F18; Gene Expression Regulation; Locomotion; Male; Nucleus Accumbens; Positron-Emission Tomography; Protein Binding; Psychotropic Drugs; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Tritium; Vitamin K 1

2012
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Administration, Inhalation; Adult; Benzamides; Caudate Nucleus; Dopamine; Dronabinol; Female; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Risk Factors; Substance-Related Disorders

2013